GRANISETRON MYLAN

Main information

  • Trade name:
  • GRANISETRON MYLAN Film-coated tablet 1MG
  • Dosage:
  • 1MG
  • Pharmaceutical form:
  • Film-coated tablet
  • Administration route:
  • Oral use
  • Units in package:
  • 1 Blister
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • GRANISETRON MYLAN Film-coated tablet 1MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • GRANISETRON
  • Product summary:
  • GRANISETRON MYLAN

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 20/ 339/06-C
  • Last update:
  • 16-01-2018

23-7-2018

SANCUSO (Kyowa Kirin Holdings B.V.)

SANCUSO (Kyowa Kirin Holdings B.V.)

SANCUSO (Active substance: granisetron) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)4891 of Mon, 23 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2296/T/52

Europe -DG Health and Food Safety